analyzed early increased IL-8 level(2-4 weeks after anti-PD-1) was associated with lower response rate in patients with MM (P<0.001) and NSCLC (P=0.001) with high sensitivity and specificity (57). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.